1. Home
  2. TKO vs RDY Comparison

TKO vs RDY Comparison

Compare TKO & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$202.13

Market Cap

14.5B

Sector

N/A

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.20

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKO
RDY
Founded
1980
1984
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TKO
RDY
Price
$202.13
$14.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
1
Target Price
$217.47
$16.90
AVG Volume (30 Days)
1.1M
938.9K
Earning Date
11-05-2025
01-22-2026
Dividend Yield
1.50%
0.50%
EPS Growth
N/A
9.95
EPS
1.85
0.79
Revenue
$2,545,175,000.00
$3,851,623,984.00
Revenue This Year
$69.99
$6.16
Revenue Next Year
$29.75
$2.57
P/E Ratio
$109.02
$17.87
Revenue Growth
N/A
14.10
52 Week Low
$133.07
$12.26
52 Week High
$212.49
$16.17

Technical Indicators

Market Signals
Indicator
TKO
RDY
Relative Strength Index (RSI) 69.55 57.67
Support Level $176.00 $13.64
Resistance Level $194.86 $14.20
Average True Range (ATR) 5.11 0.16
MACD 2.15 0.05
Stochastic Oscillator 98.21 98.25

Price Performance

Historical Comparison
TKO
RDY

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events, sponsorship, and consumer products licensing agreements of UFC-branded products.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: